HEADER LYASE 19-JAN-10 3LG3 TITLE 1.4A CRYSTAL STRUCTURE OF ISOCITRATE LYASE FROM YERSINIA PESTIS CO92 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOCITRATE LYASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 4.1.3.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: YERSINIA PESTIS; SOURCE 3 ORGANISM_TAXID: 632; SOURCE 4 STRAIN: CO92; SOURCE 5 GENE: ACEA, Y0016, YPO3725, YP_3087; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 CODONPLUS(DE3) RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG7 KEYWDS ISOCITRATE LYASE, CONSERVED, CD, PROTEOMICS EVIDENCE (CYTOPLASMID OR KEYWDS 2 PERIPLASMIC), DRUG TARGET FUNCTIONS, LYASE, STRUCTURAL GENOMICS, KEYWDS 3 CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID EXPDTA X-RAY DIFFRACTION AUTHOR S.S.SHARMA,J.S.BRUNZELLE,T.SKARINA,A.SAVCHENKO,W.F.ANDERSON,CENTER AUTHOR 2 FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES (CSGID) REVDAT 2 14-DEC-11 3LG3 1 AUTHOR REVDAT 1 14-APR-10 3LG3 0 JRNL AUTH S.S.SHARMA,J.S.BRUNZELLE,Z.WAWRZAK,T.SKARINA,E.GORDON, JRNL AUTH 2 A.SAVCHENKO,W.F.ANDERSON JRNL TITL 1.4A CRYSTAL STRUCTURE OF ISOCITRATE LYASE FROM YERSINIA JRNL TITL 2 PESTIS CO92 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.4_115) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.56 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 179982 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.133 REMARK 3 R VALUE (WORKING SET) : 0.131 REMARK 3 FREE R VALUE : 0.165 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 9030 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.5614 - 3.0080 0.98 17891 955 0.1378 0.1550 REMARK 3 2 3.0080 - 2.3882 1.00 17805 909 0.1352 0.1607 REMARK 3 3 2.3882 - 2.0865 1.00 17699 919 0.1230 0.1466 REMARK 3 4 2.0865 - 1.8958 0.99 17588 907 0.1218 0.1590 REMARK 3 5 1.8958 - 1.7600 0.98 17342 950 0.1164 0.1568 REMARK 3 6 1.7600 - 1.6562 0.97 17149 923 0.1116 0.1613 REMARK 3 7 1.6562 - 1.5733 0.96 16976 893 0.1144 0.1777 REMARK 3 8 1.5733 - 1.5048 0.95 16699 884 0.1144 0.1737 REMARK 3 9 1.5048 - 1.4469 0.92 16228 870 0.1359 0.2087 REMARK 3 10 1.4469 - 1.4000 0.89 15575 820 0.1575 0.2317 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.38 REMARK 3 B_SOL : 36.00 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 6878 REMARK 3 ANGLE : 0.913 9374 REMARK 3 CHIRALITY : 0.066 997 REMARK 3 PLANARITY : 0.004 1253 REMARK 3 DIHEDRAL : 16.362 2459 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3LG3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JAN-10. REMARK 100 THE RCSB ID CODE IS RCSB057234. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97856 REMARK 200 MONOCHROMATOR : SINGLE DIAMOND 111 REMARK 200 OPTICS : BE LENES REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 185843 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.51900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.860 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: CRANK, ARPWARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M LICITRATE, PEG3350 20%, 10MM ISO REMARK 280 CITRIC ACID, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.41750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.41750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 47.08150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 57.56650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 47.08150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 57.56650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 87.41750 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 47.08150 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 57.56650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 87.41750 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 47.08150 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 57.56650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 28470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 54560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -181.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 87.41750 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 954 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 420 REMARK 465 SER A 421 REMARK 465 SER A 422 REMARK 465 VAL A 423 REMARK 465 THR A 424 REMARK 465 ALA A 425 REMARK 465 LEU A 426 REMARK 465 THR A 427 REMARK 465 GLY A 428 REMARK 465 SER A 429 REMARK 465 THR A 430 REMARK 465 GLU A 431 REMARK 465 GLU A 432 REMARK 465 GLN A 433 REMARK 465 GLN A 434 REMARK 465 PHE A 435 REMARK 465 MSE B 1 REMARK 465 GLY B 197 REMARK 465 HIS B 198 REMARK 465 MSE B 199 REMARK 465 GLY B 419 REMARK 465 ALA B 420 REMARK 465 SER B 421 REMARK 465 SER B 422 REMARK 465 VAL B 423 REMARK 465 THR B 424 REMARK 465 ALA B 425 REMARK 465 LEU B 426 REMARK 465 THR B 427 REMARK 465 GLY B 428 REMARK 465 SER B 429 REMARK 465 THR B 430 REMARK 465 GLU B 431 REMARK 465 GLU B 432 REMARK 465 GLN B 433 REMARK 465 GLN B 434 REMARK 465 PHE B 435 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 27 31.32 -89.77 REMARK 500 ASP A 99 15.36 -158.01 REMARK 500 ALA A 100 51.91 -159.21 REMARK 500 GLN A 110 34.95 -141.69 REMARK 500 GLU A 160 -126.12 52.37 REMARK 500 PRO A 227 48.68 -82.55 REMARK 500 VAL A 383 -63.66 -121.81 REMARK 500 CYS B 44 77.95 -118.62 REMARK 500 ASP B 99 14.99 -157.54 REMARK 500 ALA B 100 51.56 -159.19 REMARK 500 GLN B 110 39.33 -140.34 REMARK 500 GLU B 160 -125.35 55.95 REMARK 500 PRO B 227 49.18 -82.77 REMARK 500 VAL B 383 -62.24 -122.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1074 DISTANCE = 5.50 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: IDP02638 RELATED DB: TARGETDB DBREF 3LG3 A 1 435 UNP Q7CLE1 Q7CLE1_YERPE 1 435 DBREF 3LG3 B 1 435 UNP Q7CLE1 Q7CLE1_YERPE 1 435 SEQRES 1 A 435 MSE THR ILE SER ARG THR GLN GLN ILE GLN GLN LEU GLU SEQRES 2 A 435 GLN GLU TRP THR SER PRO ARG TRP LYS ASN ILE THR ARG SEQRES 3 A 435 PRO TYR SER ALA GLU ASP VAL ILE LYS LEU ARG GLY SER SEQRES 4 A 435 VAL ASN PRO GLU CYS THR PHE ALA GLN ASN GLY ALA LYS SEQRES 5 A 435 LYS LEU TRP GLU LEU LEU HIS GLY GLY SER ARG LYS GLY SEQRES 6 A 435 TYR ILE ASN CYS LEU GLY ALA LEU THR GLY GLY GLN ALA SEQRES 7 A 435 LEU GLN GLN ALA LYS ALA GLY VAL GLU ALA ILE TYR MSE SEQRES 8 A 435 SER GLY TRP GLN VAL ALA ALA ASP ALA ASN THR ALA SER SEQRES 9 A 435 SER MSE TYR PRO ASP GLN SER LEU TYR PRO VAL ASP SER SEQRES 10 A 435 VAL PRO ALA VAL VAL LYS ARG ILE ASN ASN SER PHE ARG SEQRES 11 A 435 ARG ALA ASP GLN ILE GLN TRP SER ASN ASN ILE GLU PRO SEQRES 12 A 435 GLY SER LYS GLY TYR THR ASP TYR PHE LEU PRO ILE VAL SEQRES 13 A 435 ALA ASP ALA GLU ALA GLY PHE GLY GLY VAL LEU ASN ALA SEQRES 14 A 435 PHE GLU LEU MSE LYS ALA MSE ILE GLU ALA GLY ALA ALA SEQRES 15 A 435 GLY VAL HIS PHE GLU ASP GLN LEU ALA ALA VAL LYS LYS SEQRES 16 A 435 CYS GLY HIS MSE GLY GLY LYS VAL LEU VAL PRO THR GLN SEQRES 17 A 435 GLU ALA ILE GLN LYS LEU VAL ALA ALA ARG LEU ALA ALA SEQRES 18 A 435 ASP VAL LEU GLY VAL PRO THR LEU LEU ILE ALA ARG THR SEQRES 19 A 435 ASP ALA ASP ALA ALA ASP LEU LEU THR SER ASP CYS ASP SEQRES 20 A 435 PRO TYR ASP ARG GLU PHE ILE THR GLY ASP ARG THR ALA SEQRES 21 A 435 GLU GLY PHE PHE ARG THR ARG ALA GLY ILE GLU GLN ALA SEQRES 22 A 435 ILE SER ARG GLY LEU ALA TYR ALA PRO TYR ALA ASP LEU SEQRES 23 A 435 VAL TRP CYS GLU THR SER THR PRO ASP LEU ALA LEU ALA SEQRES 24 A 435 LYS ARG PHE ALA ASP ALA VAL HIS ALA GLN PHE PRO GLY SEQRES 25 A 435 LYS LEU LEU ALA TYR ASN CYS SER PRO SER PHE ASN TRP SEQRES 26 A 435 LYS LYS ASN LEU THR ASP GLN GLN ILE ALA SER PHE GLN SEQRES 27 A 435 ASP GLU LEU SER ALA MSE GLY TYR LYS TYR GLN PHE ILE SEQRES 28 A 435 THR LEU ALA GLY ILE HIS SER MSE TRP PHE ASN MSE PHE SEQRES 29 A 435 ASP LEU ALA HIS ALA TYR ALA GLN GLY GLU GLY MSE LYS SEQRES 30 A 435 HIS TYR VAL GLU LYS VAL GLN GLN PRO GLU PHE ALA SER SEQRES 31 A 435 VAL ASP ARG GLY TYR THR PHE ALA SER HIS GLN GLN GLU SEQRES 32 A 435 VAL GLY THR GLY TYR PHE ASP LYS VAL THR ASN ILE ILE SEQRES 33 A 435 GLN GLY GLY ALA SER SER VAL THR ALA LEU THR GLY SER SEQRES 34 A 435 THR GLU GLU GLN GLN PHE SEQRES 1 B 435 MSE THR ILE SER ARG THR GLN GLN ILE GLN GLN LEU GLU SEQRES 2 B 435 GLN GLU TRP THR SER PRO ARG TRP LYS ASN ILE THR ARG SEQRES 3 B 435 PRO TYR SER ALA GLU ASP VAL ILE LYS LEU ARG GLY SER SEQRES 4 B 435 VAL ASN PRO GLU CYS THR PHE ALA GLN ASN GLY ALA LYS SEQRES 5 B 435 LYS LEU TRP GLU LEU LEU HIS GLY GLY SER ARG LYS GLY SEQRES 6 B 435 TYR ILE ASN CYS LEU GLY ALA LEU THR GLY GLY GLN ALA SEQRES 7 B 435 LEU GLN GLN ALA LYS ALA GLY VAL GLU ALA ILE TYR MSE SEQRES 8 B 435 SER GLY TRP GLN VAL ALA ALA ASP ALA ASN THR ALA SER SEQRES 9 B 435 SER MSE TYR PRO ASP GLN SER LEU TYR PRO VAL ASP SER SEQRES 10 B 435 VAL PRO ALA VAL VAL LYS ARG ILE ASN ASN SER PHE ARG SEQRES 11 B 435 ARG ALA ASP GLN ILE GLN TRP SER ASN ASN ILE GLU PRO SEQRES 12 B 435 GLY SER LYS GLY TYR THR ASP TYR PHE LEU PRO ILE VAL SEQRES 13 B 435 ALA ASP ALA GLU ALA GLY PHE GLY GLY VAL LEU ASN ALA SEQRES 14 B 435 PHE GLU LEU MSE LYS ALA MSE ILE GLU ALA GLY ALA ALA SEQRES 15 B 435 GLY VAL HIS PHE GLU ASP GLN LEU ALA ALA VAL LYS LYS SEQRES 16 B 435 CYS GLY HIS MSE GLY GLY LYS VAL LEU VAL PRO THR GLN SEQRES 17 B 435 GLU ALA ILE GLN LYS LEU VAL ALA ALA ARG LEU ALA ALA SEQRES 18 B 435 ASP VAL LEU GLY VAL PRO THR LEU LEU ILE ALA ARG THR SEQRES 19 B 435 ASP ALA ASP ALA ALA ASP LEU LEU THR SER ASP CYS ASP SEQRES 20 B 435 PRO TYR ASP ARG GLU PHE ILE THR GLY ASP ARG THR ALA SEQRES 21 B 435 GLU GLY PHE PHE ARG THR ARG ALA GLY ILE GLU GLN ALA SEQRES 22 B 435 ILE SER ARG GLY LEU ALA TYR ALA PRO TYR ALA ASP LEU SEQRES 23 B 435 VAL TRP CYS GLU THR SER THR PRO ASP LEU ALA LEU ALA SEQRES 24 B 435 LYS ARG PHE ALA ASP ALA VAL HIS ALA GLN PHE PRO GLY SEQRES 25 B 435 LYS LEU LEU ALA TYR ASN CYS SER PRO SER PHE ASN TRP SEQRES 26 B 435 LYS LYS ASN LEU THR ASP GLN GLN ILE ALA SER PHE GLN SEQRES 27 B 435 ASP GLU LEU SER ALA MSE GLY TYR LYS TYR GLN PHE ILE SEQRES 28 B 435 THR LEU ALA GLY ILE HIS SER MSE TRP PHE ASN MSE PHE SEQRES 29 B 435 ASP LEU ALA HIS ALA TYR ALA GLN GLY GLU GLY MSE LYS SEQRES 30 B 435 HIS TYR VAL GLU LYS VAL GLN GLN PRO GLU PHE ALA SER SEQRES 31 B 435 VAL ASP ARG GLY TYR THR PHE ALA SER HIS GLN GLN GLU SEQRES 32 B 435 VAL GLY THR GLY TYR PHE ASP LYS VAL THR ASN ILE ILE SEQRES 33 B 435 GLN GLY GLY ALA SER SER VAL THR ALA LEU THR GLY SER SEQRES 34 B 435 THR GLU GLU GLN GLN PHE MODRES 3LG3 MSE A 1 MET SELENOMETHIONINE MODRES 3LG3 MSE A 91 MET SELENOMETHIONINE MODRES 3LG3 MSE A 106 MET SELENOMETHIONINE MODRES 3LG3 MSE A 173 MET SELENOMETHIONINE MODRES 3LG3 MSE A 176 MET SELENOMETHIONINE MODRES 3LG3 MSE A 199 MET SELENOMETHIONINE MODRES 3LG3 MSE A 344 MET SELENOMETHIONINE MODRES 3LG3 MSE A 359 MET SELENOMETHIONINE MODRES 3LG3 MSE A 363 MET SELENOMETHIONINE MODRES 3LG3 MSE A 376 MET SELENOMETHIONINE MODRES 3LG3 MSE B 91 MET SELENOMETHIONINE MODRES 3LG3 MSE B 106 MET SELENOMETHIONINE MODRES 3LG3 MSE B 173 MET SELENOMETHIONINE MODRES 3LG3 MSE B 176 MET SELENOMETHIONINE MODRES 3LG3 MSE B 344 MET SELENOMETHIONINE MODRES 3LG3 MSE B 359 MET SELENOMETHIONINE MODRES 3LG3 MSE B 363 MET SELENOMETHIONINE MODRES 3LG3 MSE B 376 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 91 8 HET MSE A 106 8 HET MSE A 173 8 HET MSE A 176 8 HET MSE A 199 8 HET MSE A 344 8 HET MSE A 359 8 HET MSE A 363 8 HET MSE A 376 8 HET MSE B 91 8 HET MSE B 106 8 HET MSE B 173 8 HET MSE B 176 8 HET MSE B 344 8 HET MSE B 359 8 HET MSE B 363 8 HET MSE B 376 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 18(C5 H11 N O2 SE) FORMUL 3 HOH *1173(H2 O) HELIX 1 1 SER A 4 TRP A 16 1 13 HELIX 2 2 THR A 17 LYS A 22 5 6 HELIX 3 3 SER A 29 LEU A 36 1 8 HELIX 4 4 CYS A 44 HIS A 59 1 16 HELIX 5 5 THR A 74 GLY A 85 1 12 HELIX 6 6 SER A 92 ALA A 100 1 9 HELIX 7 7 ASP A 116 ASN A 139 1 24 HELIX 8 8 GLY A 165 GLY A 180 1 16 HELIX 9 9 LEU A 190 LYS A 194 5 5 HELIX 10 10 PRO A 206 GLY A 225 1 20 HELIX 11 11 ASP A 247 GLU A 252 5 6 HELIX 12 12 GLY A 269 ALA A 281 1 13 HELIX 13 13 PRO A 282 ALA A 284 5 3 HELIX 14 14 ASP A 295 PHE A 310 1 16 HELIX 15 15 ASN A 324 LEU A 329 1 6 HELIX 16 16 THR A 330 MSE A 344 1 15 HELIX 17 17 LEU A 353 GLY A 373 1 21 HELIX 18 18 GLU A 374 VAL A 383 1 10 HELIX 19 19 VAL A 383 ALA A 389 1 7 HELIX 20 20 SER A 390 GLY A 394 5 5 HELIX 21 21 SER A 399 VAL A 404 1 6 HELIX 22 22 GLY A 405 GLY A 418 1 14 HELIX 23 23 SER B 4 TRP B 16 1 13 HELIX 24 24 THR B 17 LYS B 22 5 6 HELIX 25 25 SER B 29 LEU B 36 1 8 HELIX 26 26 CYS B 44 HIS B 59 1 16 HELIX 27 27 THR B 74 GLY B 85 1 12 HELIX 28 28 SER B 92 ALA B 100 1 9 HELIX 29 29 ASP B 116 ASN B 139 1 24 HELIX 30 30 GLY B 165 GLY B 180 1 16 HELIX 31 31 LEU B 190 LYS B 194 5 5 HELIX 32 32 PRO B 206 GLY B 225 1 20 HELIX 33 33 ASP B 247 GLU B 252 5 6 HELIX 34 34 GLY B 269 ALA B 281 1 13 HELIX 35 35 ASP B 295 PHE B 310 1 16 HELIX 36 36 ASN B 324 LEU B 329 1 6 HELIX 37 37 THR B 330 MSE B 344 1 15 HELIX 38 38 LEU B 353 GLY B 373 1 21 HELIX 39 39 GLU B 374 VAL B 383 1 10 HELIX 40 40 VAL B 383 SER B 390 1 8 HELIX 41 41 VAL B 391 GLY B 394 5 4 HELIX 42 42 SER B 399 VAL B 404 1 6 HELIX 43 43 GLY B 405 GLY B 418 1 14 SHEET 1 A 8 ILE A 67 LEU A 70 0 SHEET 2 A 8 TYR A 346 ILE A 351 1 O GLN A 349 N ILE A 67 SHEET 3 A 8 LEU A 314 ASN A 318 1 N TYR A 317 O TYR A 348 SHEET 4 A 8 LEU A 286 CYS A 289 1 N VAL A 287 O ALA A 316 SHEET 5 A 8 LEU A 229 THR A 234 1 N THR A 234 O TRP A 288 SHEET 6 A 8 GLY A 183 GLU A 187 1 N PHE A 186 O ARG A 233 SHEET 7 A 8 ILE A 155 ASP A 158 1 N ALA A 157 O GLY A 183 SHEET 8 A 8 ILE A 89 MSE A 91 1 N ILE A 89 O VAL A 156 SHEET 1 B 4 VAL A 203 LEU A 204 0 SHEET 2 B 4 LEU A 241 LEU A 242 1 O LEU A 241 N LEU A 204 SHEET 3 B 4 PHE A 264 THR A 266 -1 O PHE A 264 N LEU A 242 SHEET 4 B 4 ILE A 254 ARG A 258 -1 N ASP A 257 O ARG A 265 SHEET 1 C 8 ILE B 67 LEU B 70 0 SHEET 2 C 8 TYR B 346 ILE B 351 1 O GLN B 349 N ILE B 67 SHEET 3 C 8 LEU B 314 ASN B 318 1 N TYR B 317 O TYR B 348 SHEET 4 C 8 LEU B 286 CYS B 289 1 N VAL B 287 O ALA B 316 SHEET 5 C 8 LEU B 229 THR B 234 1 N ALA B 232 O LEU B 286 SHEET 6 C 8 GLY B 183 GLU B 187 1 N PHE B 186 O ARG B 233 SHEET 7 C 8 ILE B 155 ASP B 158 1 N ALA B 157 O GLY B 183 SHEET 8 C 8 ILE B 89 MSE B 91 1 N MSE B 91 O VAL B 156 SHEET 1 D 4 VAL B 203 LEU B 204 0 SHEET 2 D 4 LEU B 241 LEU B 242 1 O LEU B 241 N LEU B 204 SHEET 3 D 4 PHE B 264 THR B 266 -1 O PHE B 264 N LEU B 242 SHEET 4 D 4 ILE B 254 ARG B 258 -1 N ASP B 257 O ARG B 265 LINK C MSE A 1 N THR A 2 1555 1555 1.33 LINK C TYR A 90 N MSE A 91 1555 1555 1.33 LINK C MSE A 91 N SER A 92 1555 1555 1.33 LINK C SER A 105 N MSE A 106 1555 1555 1.32 LINK C MSE A 106 N TYR A 107 1555 1555 1.33 LINK C LEU A 172 N MSE A 173 1555 1555 1.32 LINK C MSE A 173 N LYS A 174 1555 1555 1.33 LINK C ALA A 175 N MSE A 176 1555 1555 1.33 LINK C MSE A 176 N ILE A 177 1555 1555 1.33 LINK C HIS A 198 N MSE A 199 1555 1555 1.33 LINK C MSE A 199 N GLY A 200 1555 1555 1.33 LINK C ALA A 343 N MSE A 344 1555 1555 1.33 LINK C MSE A 344 N GLY A 345 1555 1555 1.33 LINK C SER A 358 N MSE A 359 1555 1555 1.33 LINK C MSE A 359 N TRP A 360 1555 1555 1.33 LINK C ASN A 362 N MSE A 363 1555 1555 1.33 LINK C MSE A 363 N PHE A 364 1555 1555 1.33 LINK C GLY A 375 N MSE A 376 1555 1555 1.33 LINK C MSE A 376 N LYS A 377 1555 1555 1.33 LINK C TYR B 90 N MSE B 91 1555 1555 1.33 LINK C MSE B 91 N SER B 92 1555 1555 1.33 LINK C SER B 105 N MSE B 106 1555 1555 1.33 LINK C MSE B 106 N TYR B 107 1555 1555 1.33 LINK C LEU B 172 N MSE B 173 1555 1555 1.33 LINK C MSE B 173 N LYS B 174 1555 1555 1.33 LINK C ALA B 175 N MSE B 176 1555 1555 1.34 LINK C MSE B 176 N ILE B 177 1555 1555 1.33 LINK C ALA B 343 N MSE B 344 1555 1555 1.33 LINK C MSE B 344 N GLY B 345 1555 1555 1.33 LINK C SER B 358 N MSE B 359 1555 1555 1.33 LINK C MSE B 359 N TRP B 360 1555 1555 1.33 LINK C ASN B 362 N MSE B 363 1555 1555 1.33 LINK C MSE B 363 N PHE B 364 1555 1555 1.33 LINK C GLY B 375 N MSE B 376 1555 1555 1.33 LINK C MSE B 376 N LYS B 377 1555 1555 1.33 CRYST1 94.163 115.133 174.835 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010620 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008686 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005720 0.00000 HETATM 1 N MSE A 1 -7.308 45.502 44.511 1.00 42.72 N ANISOU 1 N MSE A 1 3799 6264 6168 -45 -1299 -452 N HETATM 2 CA MSE A 1 -8.451 45.791 43.652 1.00 45.05 C ANISOU 2 CA MSE A 1 5283 5936 5897 471 -1282 -1006 C HETATM 3 C MSE A 1 -8.962 44.521 42.982 1.00 49.21 C ANISOU 3 C MSE A 1 5883 6526 6290 871 -1031 -1610 C HETATM 4 O MSE A 1 -8.186 43.770 42.391 1.00 50.31 O ANISOU 4 O MSE A 1 5294 7002 6818 2182 -1123 -1658 O HETATM 5 CB MSE A 1 -8.068 46.821 42.587 1.00 40.88 C ANISOU 5 CB MSE A 1 4297 5779 5457 324 -760 -93 C HETATM 6 CG MSE A 1 -7.605 48.153 43.150 1.00 37.51 C ANISOU 6 CG MSE A 1 3665 4609 5979 1921 -955 -535 C HETATM 7 SE MSE A 1 -9.067 49.319 43.684 0.52 37.09 SE ANISOU 7 SE MSE A 1 4119 5841 4132 1480 -966 -1547 SE HETATM 8 CE MSE A 1 -9.595 49.981 41.922 1.00 44.50 C ANISOU 8 CE MSE A 1 6258 6597 4055 -584 -1706 -1058 C